{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Nashville",
      "state": "TN",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76103",
      "recalling_firm": "VIRTUS PHARMACEUTICALS OPCO II L",
      "address_1": "1321 Murfreesboro Pike #",
      "address_2": "N/A",
      "postal_code": "37217-2726",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0241-2017",
      "product_description": "VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30",
      "product_quantity": "124,250 bottles",
      "reason_for_recall": "cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.",
      "recall_initiation_date": "20161212",
      "center_classification_date": "20161228",
      "termination_date": "20180821",
      "report_date": "20170104",
      "code_info": "Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017,  21512164 Exp. date 11/30/2017"
    }
  ]
}